Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
2235 Views
Dr Sanjay Kalra, DM, Bharti Hospital, Karnal Immediate Past President, Endocrine Society of India 02 June 2021
A study has identified older age, obesity, heart disease and use of steroids and SGLT2 inhibitors prior to hospitalization for Covid-19 as factors that increase the risk of severe Covid-19 in persons with diabetes. These findings from a retrospective study were presented at the recently concluded annual meeting of the American Association of Clinical Endocrinology (AACE) (May 26-29, 2021 virtual meeting).
Patients who had blood glucose levels out of the reference range had greater chances of developing severe infection. About 44% of diabetic patients with severe Covid-19 had glucose levels > 180 mg/dL compared to 38% of those who did not have severe infection. Patients with severe Covid-19 also had more hypoglycaemic episodes compared to patients who did not have severe infection (9.75% vs 8.90%).
The multicenter study analysed 1818 people with diabetes who were hospitalized with COVID-19. Patients who required intensive care, or met clinical criteria indicating acute respiratory distress syndrome (ARDS) or tachypnea (respiratory rate >30) or SpO2 <93% or PF ratio <300 or those who died were categorised as severe COVID-19.
History of use of an SGLT-2 inhibitor (such as canagliflozin, empagliflozin, dapagliflozin) prior to hospitalization for Covid-19 was associated with an 85% greater chance of having a severe COVID-19 infection (OR = 1.85). A similar high risk of severe Covid-19 was observed with pre-hospitalization exposure to steroids (OR = 1.49). No such association was seen with use of ACEIs (OR 0.75) or statin (OR 0.66).
Older people with diabetes (OR = 1.01) were more likely to have severe disease as did males (OR = 1.37).
A significantly increased risk for severe Covid-19 infection was seen in obese persons with BMI >35 kg/m2 (OR = 1.83) or those having neuropathy (OR = 1.65) or heart disease (OR = 1.3).
The study authors are hopeful that their study findings would help in better triage of patients with diabetes at greater risk of severe Covid-19 for timely and intensive clinical interventions to improve outcomes in this group of patients.
(Source: Medpage Today, May 28, 2021)
Dr Sanjay Kalra,
DM, Bharti Hospital, KarnalImmediate Past President, Endocrine Society of India
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}